Literature DB >> 7387813

Activity of a new high efficiency diuretic in man: piretanide (HOE 118).

N Pozet, A Hadj-Aissa, M Pellet, J Traeger.   

Abstract

1 The pharmacological actions of piretanide, a new high efficiency diuretic, were studied in sixteen patients with GFR (inulin clearance) varying from 0.1--2.5 ml/s. 2 After hydration and following two control periods, a single dose of 6 mg piretanide was ingested. Thereafter, urine was collected every 30 min for 2 h and every hour for the next 4 h. Fluid losses were replaced. 3 The following measurements were made: urine flow rate, clearances of inulin, PAH, urea, creatinine, uric acid, osmolar and free water clearances, excretion rates of sodium, chloride, potassium, calcium, phosphate, bicarbonate, ammonium, titratable acidity and urine pH. 4 Main results showed piretanide was efficient in the group with normal GFR (inulin clearance greater than 1.5 ml/s) and in the group with slightly decreased GFR (1.0 less than inulin clearance less than 1.4 ml/s), in terms of diuresis, natriuresis, kaliuresis and calciuresis. It was inefficient in the group with severe renal insufficiency (inulin clearance less than 0.3 ml/s). 5 Free water clearance showed preservation of diluting ability to a large extent. 6 In the three groups, no significant change in inulin clearance and PAH clearance occurred.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387813      PMCID: PMC1429998          DOI: 10.1111/j.1365-2125.1980.tb01083.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Determination of uric acid in serum by a carbonate method.

Authors:  W T CARAWAY
Journal:  Am J Clin Pathol       Date:  1955-07       Impact factor: 2.493

2.  Differences in the acute effects of furosemide and ethacrynic acid in man.

Authors:  J H Stein; C B Wilson; W M Kirkendall
Journal:  J Lab Clin Med       Date:  1968-04

3.  Furosemide. A clinical evaluation of its diuretic action.

Authors:  W B Stason; P J Cannon; H O Heinemann; J H Laragh
Journal:  Circulation       Date:  1966-11       Impact factor: 29.690

4.  Kinetic and dynamic comparison of piretanide and furosemide.

Authors:  J R Lawrence; A F Ansari; H L Elliott; D J Sumner; G F Brunton; B Whiting; R Whitesmith
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

5.  A semi-automated determination of phospholipids.

Authors:  M Kraml
Journal:  Clin Chim Acta       Date:  1966-04       Impact factor: 3.786

6.  Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.

Authors:  C J Roberts; M Homeida; F Roberts; W Bogie
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

  6 in total
  10 in total

Review 1.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

3.  Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.

Authors:  C Marone; F C Reubi; W Lahn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Protein binding of piretanide in normal and uraemic serum.

Authors:  H L Elliott; A F Ansari; B C Campbell; J R Lawrence
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Kinetics of a high dose of piretanide in renal failure.

Authors:  J L Brazier; N Pozet; G Faucon; J Traeger; A Hadj-Haissa
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  The effects of a combination of piretanide and triamterene in healthy subjects.

Authors:  T K Daneshmend; M Homeida; C J Roberts; S Dombey
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

Review 7.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

8.  Oral piretanide in chronic renal failure.

Authors:  I S Henderson; T J Beattie; A C Kennedy; S L Dombey
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

9.  The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency.

Authors:  K J Berg; R A Walstad; K Bergh
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

10.  Acute effect of high dose (48 mg) of piretanide in advanced renal insufficiency.

Authors:  A Hadj Aissa; N Pozet; M Labeeuw; M Pellet; J Traeger
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.